Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improved Prostate Cancer Diagnosis - Combination of Magnetic Resonance Imaging Targeted Biopsies and Biomarkers (Multi-institutional Study)

NCT02241122 is registered in ClinicalTrials.gov with Turku University Hospital as lead sponsor.

NCT NCT02241122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02241122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improved Prostate Cancer Diagnosis - Combination of Magnetic Resonance Imaging Targeted Biopsies and Biomarkers (Multi-institutional Study)
Lead sponsor
Turku University Hospital
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2015
Completion date
April 1, 2018
Enrollment
350 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer